Bespoke Extracts (BSPK) Operating Income (2014 - 2025)
Bespoke Extracts (BSPK) reported Operating Income of -$53891.0 for Q3 2025, up 79.47% on a YoY basis from -$30028.3 in Q3 2024, and up 66.73% sequentially from -$161958.0 in Q2 2025.
Bespoke Extracts (BSPK) Operating Income (2014 - 2025) Analysis & Trends
Bespoke Extracts (BSPK) has 12 years of Operating Income data on file, last reported at -$53891.0 in Q3 2025.
- For the quarter ending Q3 2025, Operating Income rose 79.47% year-over-year to -$53891.0; the trailing twelve-month figure through Sep 2025 stood at -$640301.0 (up 40.74% YoY), and the FY2024 full-year result was -$994628.0, up 32.43% from the prior year.
- Operating Income improved to -$53891.0 in Q3 2025, from -$161958.0 in the prior quarter.
- In the past five years, Operating Income ranged from a high of $3.0 million in Q3 2021 to a low of -$1.1 million in Q3 2022.
- A 5-year average of -$245110.7 and a median of -$296192.0 in 2023 frame the typical range for Operating Income.
- Peak annual rise in Operating Income reached 90.67% in 2021, while the deepest fall reached 4.19% in 2021.
- Tracing BSPK's Operating Income over 5 years: stood at -$67933.0 in 2021, then sank by 1226.57% to -$901176.0 in 2022, then surged by 70.6% to -$264914.0 in 2023, then soared by 32.39% to -$179114.0 in 2024, then soared by 69.91% to -$53891.0 in 2025.
- Business Quant data shows BSPK's Operating Income at -$53891.0 in Q3 2025, -$161958.0 in Q2 2025, and -$245338.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 652.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 833.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -2.65 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 325.80 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | -79.70 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 193.40 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 291.00 Mn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 | -53,891.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -53,891.00 |
| Jun 30, 2025 | -161,958.00 |
| Mar 31, 2025 | -245,338.00 |
| Dec 31, 2024 | -179,114.00 |
| Sep 30, 2024 | -262,468.00 |
| Jun 30, 2024 | -250,243.00 |
| Mar 31, 2024 | -302,803.00 |
| Dec 31, 2023 | -264,914.00 |
| Sep 30, 2023 | -296,192.00 |
| Jun 30, 2023 | -467,502.00 |
| Mar 31, 2023 | -443,370.00 |
| Dec 31, 2022 | -901,176.00 |
| Sep 30, 2022 | -1.13 Mn |
| Jun 30, 2022 | -1.01 Mn |
| Mar 31, 2022 | -972,675.00 |
| Nov 30, 2021 | -67,933.00 |
| Aug 31, 2021 | 2.96 Mn |
| May 31, 2021 | -299,571.00 |
| Feb 28, 2021 | -304,171.00 |
| Nov 30, 2020 | -202,106.00 |